Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176497).
- Psoriatic Arthritis Study of Izokibep: Complete Statistical AnalysisIndependent statistical analysis of Psoriatic Arthritis Study of Izokibep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05623345).
- PSUNRISE – Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: Complete Statistical AnalysisIndependent statistical analysis of PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Psychological Support for Patients With an Implantable Cardioverter Defibrillator: Complete Statistical AnalysisIndependent statistical analysis of Psychological Support for Patients With an Implantable Cardioverter Defibrillator: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00152763).
- Psychopharmacology for Cocaine Dependence – Buspirone: Complete Statistical AnalysisIndependent statistical analysis of Psychopharmacology for Cocaine Dependence - Buspirone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01267292).
- PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00686842).
- PTCLIndependent statistical analysis of Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00865969).
- PTH Analog Type II Odontoid Fracture: Complete Statistical AnalysisIndependent statistical analysis of PTH Analog Type II Odontoid Fracture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04760782).
- PTI-125 for Mild-to-moderate Alzheimer’s Disease Patients: Complete Statistical AnalysisIndependent statistical analysis of PTI-125 for Mild-to-moderate Alzheimer's Disease Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03748706).
- PTNS-MIndependent statistical analysis of Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PTNS-MSIndependent statistical analysis of PTNS for Female Patients Suffering From Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05422625).
- PTOTtAVRIndependent statistical analysis of Physical Therapy and Occupational Therapy After Transcatheter Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03117296).
- PTP-NPIndependent statistical analysis of Improving Functions in Veterans With Post-traumatic Peripheral Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02979925).
- PTSIndependent statistical analysis of Passive Tactile Stimulation for Stroke Rehabilitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03814889).
- PTSCIndependent statistical analysis of Persistence-Targeted Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01654107).
- PTSC-SIndependent statistical analysis of Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03873337).
- PTSDIndependent statistical analysis of Neurofeedback of Amygdala Activity for Post-traumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03574974).
- PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin’s Lymphoma That Have Not Responded to Standard Treatment: Complete Statistical AnalysisIndependent statistical analysis of PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide: Complete Statistical AnalysisIndependent statistical analysis of Public Messaging to Increase Treatment Seeking for Veterans at Risk for Suicide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pudendal Nerve Block for Hemorrhoidectomy: Complete Statistical AnalysisIndependent statistical analysis of Pudendal Nerve Block for Hemorrhoidectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04251884).
- PUFFORIndependent statistical analysis of Pulmonary Function Using Non-invasive Forced Oscillometry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03346343).
- PULIndependent statistical analysis of Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pulmonary Function After Hyperbaric Oxygen Therapy: Complete Statistical AnalysisIndependent statistical analysis of Pulmonary Function After Hyperbaric Oxygen Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05088772).
- Pulmonary Function and Interscalene Block: Complete Statistical AnalysisIndependent statistical analysis of Pulmonary Function and Interscalene Block: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02181296).
- PULSIndependent statistical analysis of Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PULSARIndependent statistical analysis of A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PULSARIndependent statistical analysis of Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal…
- Pulse Pressure and Post-epidural Fetal Heart Rate Changes: Complete Statistical AnalysisIndependent statistical analysis of Pulse Pressure and Post-epidural Fetal Heart Rate Changes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02565485).
- PULSED AFIndependent statistical analysis of Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04198701).
- Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars: Complete Statistical AnalysisIndependent statistical analysis of Pulsed Dye Laser and Affirm Laser in the Treatment of Abdominoplasty Scars: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea: Complete Statistical AnalysisIndependent statistical analysis of Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03761394).
- PUMPIndependent statistical analysis of Prometra's Utilization in Mitigating Pain (PUMP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00817596).
- PUMP-ExIndependent statistical analysis of Exercise-primed Upper Extremity Motor Practice in Chronic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04259424).
- Punctal Plug Study to Determine the Safety and Retention Times of Various Lengths of Canalicular Stents in Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Punctal Plug Study to Determine the Safety and Retention Times of Various Lengths of Canalicular Stents in Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PUP16_01Independent statistical analysis of Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02962882).
- Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PUPs B-LONGIndependent statistical analysis of Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- PuraBond PROOFIndependent statistical analysis of PuraBond® and Pain Following Resection of Oral or Oropharyngeal Mucosal Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PureWick™ France and U.S. At-Home Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of PureWick™ France and U.S. At-Home Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05710718).
- PURPOSEIndependent statistical analysis of Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PURSUITIndependent statistical analysis of A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- PUSHIndependent statistical analysis of Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063880).
- Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection: Complete Statistical AnalysisIndependent statistical analysis of Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- PVPIndependent statistical analysis of A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- PVSIndependent statistical analysis of Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…
- PyreneesIndependent statistical analysis of Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria: Complete Statistical AnalysisIndependent statistical analysis of Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…